FOUR WHISTLEBLOWERS SPLIT $84 MILLION FROM ABBOTT LABS CASE

Four former Abbott Laboratories sales staff members who tipped off the government to improper marketing of medication will split $84 million as part of the $1.6 billion settlement of a suit alleging improper marketing of Depakote. This payout is the second largest since the False Claims Act was amended in 1986 giving whistleblowers more financial incentive to come forward by awarding them part of the settlement. In 2009, Pfizer paid $2.3 billion to settle a similar case and six whistleblowers split $102 million. Abbott made the payment to settle claims that it improperly marketed the neurologic medication Depakote for off label or unapproved uses.

Posted in:
Updated:

2 responses to “FOUR WHISTLEBLOWERS SPLIT $84 MILLION FROM ABBOTT LABS CASE”

  1. Reg-Abbott labs off-label promotion of Depakote.
    I took Depakote for 6 years was ineffective for my condition PTSD,the doctor kept telling me to take it.

    The saga of the schizophrenia drugs is one of incredible profit.Eli Lilly made $65 BILLION on Zyprexa franchise. Described as *the most successful drug in the history of neuroscience*.There is a whole underclass block of our society,including children in foster care that are the market for these drugs,but have little voice of protest if harmed by them.
    –Daniel Haszard
    *tell the truth don’t be afraid*